Macrobrachium rosenbergii nodavirus (MrNv) causes white tail disease (WTD) in giant freshwater prawns, which leads to devastating economic losses in the aquaculture industry. Despite extensive research on MrNv, there is still no antiviral agent to treat WTD. Thus, the main aim of this study was to identify potential anti-MrNv molecules. A 12-mer phage-displayed peptide library was biopanned against the MrNv virus-like particle (VLP). After four rounds of biopanning, two dominant phages harbouring the amino acid sequences HTKQIPRHIYSA and VSRHQSWHPHDL were selected. An equilibrium binding assay in solution was performed to determine the relative dissociation constant (K 
INTRODUCTION
Macrobrachium rosenbergii nodavirus (MrNv) is the causative agent of white tail disease (WTD) in giant freshwater prawns [1] . Prawns infected by MrNv develop severe muscle necrosis, and the virus also causes 100 % mortality in post-larvae within 3 days of infection [2] . WTD usually results in huge economic losses in prawn industries, especially in the hatchery and nursery phases [2] . The disease was first discovered in 1997 in Guadeloupe of the French West Indies [1] and was later reported in Taiwan [3] , China [4] , India [2] , Thailand [5] , Australia [6] , Malaysia [7] and Indonesia [8] .
MrNv is grouped in the family of Nodaviridae [9] . It has a non-enveloped spherical capsid with a diameter of approximately 30 nm as determined with transmission electron microscopy [1] , and approximately 40 nm as determined with cryo-electron microscopy and image reconstruction [10] . The viral genome contains two single-stranded, linear and positive-sense RNAs: RNA1 and RNA2 [11] . The RNA1 (3.126 kb) encodes the RNA-dependent RNA polymerase and the B2-like protein [11, 12] . The RNA-dependent RNA polymerase has 1034 amino acids while the B2-like protein is composed of 133 amino acids [12] . RNA2 (1.175 kb) encodes the capsid protein, a single polypeptide consisting of 371 amino acids [11] . The MrNv capsid protein can be expressed readily in Escherichia coli, and the purified recombinant capsid protein self-assembles into a virus-like particle (VLP), closely resembling the native virus isolated from infected prawns [7] . Therefore, the MrNv VLP was used to study the viral structure [10, 13] , infection mechanism [14, 15] , as well as a carrier for the development of multi-component vaccines [16, 17] .
A phage display library, harbouring billions of random peptides, is a tool for high throughput screening of ligands that bind specifically with a given target. Several peptides were successfully selected from phage display libraries and serve as potential antiviral agents against aquaculture viruses, including grass carp haemorrhage virus which causes severe haemorrhagic disease in grass carp [18] , white spot syndrome virus, causing white spot disease in a variety of shrimps [19] , and infectious salmon anaemia virus, the causative agent of salmon anaemia [20] .
Despite an intensive study on MrNv, there is still no effective therapeutic agent available to inhibit the viral infection. Most recently, the entry mechanism of MrNv was studied using the MrNv VLP as a model [14, 15] . Therefore, the MrNv VLP is a good substrate for the screening of antiviral molecules against MrNv infection. In this study, the MrNv VLP was used as a substrate and two peptide inhibitors were isolated from a phage-displayed peptide library. These peptides bound tightly to MrNv VLP, inhibited the entry of MrNv VLP in Spodoptera frugiperda (Sf9) cells, increased the viability of the cells upon MrNv infection, and reduced the number of MrNv in infected cells, demonstrating the potential of these peptides as antiviral agents against MrNv.
RESULTS

Purification of recombinant MrNv VLP and native MrNv
The recombinant His-tagged MrNv capsid protein was purified from the E. coli clone carrying plasmid pTrcHis-TARNA2, using the immobilized metal affinity chromatography (IMAC) as described by Goh et al. [7] . Post-larvae of Macrobrachium rosenbergii with WTD symptoms were diagnosed with RT-PCR (Fig. S1 , available in the online version of this article) and the result confirmed that they were infected by MrNv. The native MrNv was purified from the post-larvae using sucrose density gradient ultracentrifugation. SDS-PAGE and Western blot analysis of the purified His-tagged MrNv capsid protein and native MrNv showed protein bands with molecular mass (M r ) of approximately 46 and 43 kDa, respectively (Fig. 1a, b) . These estimated M r corresponded well with the calculated M r of the MrNv capsid protein, which is approximately 43 kDa [11] . The Histagged MrNv capsid protein is approximately 3 kDa larger because it contains a His-tag at its C-terminal end. Apart from the expected protein bands, smaller protein bands were detected by the rabbit anti-MrNv capsid protein serum. The smaller protein bands were also reported by Goh et al. [7] , Yong et al. [16] and Kueh et al. [21] , which are the N-terminal degraded products of the capsid protein.
As shown in Fig. 1(c) , the purified His-tagged MrNv capsid protein assembled into VLPs as observed under a transmission electron microscope (TEM). The TEM micrographs also revealed that the MrNv VLP and native MrNv were both spherical in shape with diameters of 24±3 and 32 ±2 nm, respectively, which corresponded well with those observed by Goh et al. [7] and Arcier et al. [1] . The yield of the MrNv VLP was approximately 3 mg l À1 of bacterial culture while the yield of the native MrNv was approximately 1 mg g À1 of post-larvae.
Selection of peptides that interact with MrNv VLP Four rounds of biopanning were performed using the MrNv VLP as a substrate. The enrichment factor increased from round one to round three (Table 1) . In round four, the enrichment factor decreased (Table 1) when a higher concentration of Tween 20 was applied to increase the stringency of washing buffer. Thirty phage clones were selected randomly from the fourth round of biopanning, and the nucleotide sequences of the DNA inserts were determined. The deduced amino acid sequences of the selected peptides are summarized in Table 2 . Peptide HTKQIPRHIYSA appeared with the highest frequency (20 %), followed by VSRHQSWHPHDL (17 %). The 30 peptides share some similarities: (i) histidine exists abundantly, ranging from two to four residues in each of the dodecapeptides; (ii) positions adjacent to histidine residues show a preference for proline and arginine residues (underlined in Inhibition of the binding of phage-displayed peptides to MrNv VLP by the rabbit anti-MrNv capsid protein serum The two dominant phages displaying the peptide sequences HTKQIPRHIYSA (phage-HTK) and VSRHQSWHPHDL (phage-VSR) were propagated and purified to homogeneity ( Fig. S2 ) for further analysis. The phage-displayed peptides bound to the MrNv VLP, but they did not interact with the truncated hepatitis B core antigen (tHBcAg) VLP (Fig. S3) , which served as a negative control (Fig. 2) . This indicates that the phage-displayed peptides interacted specifically with MrNv VLP. The number of bound phages on MrNv VLP reduced significantly in the presence of the rabbit anti-MrNv capsid protein serum (Fig. 2) . This shows that the interactions between the phages and MrNv VLP were inhibited by the rabbit anti-MrNv capsid protein serum. The rabbit anti-HBcAg serum [22] , which served as a negative control, did not inhibit the binding of the phages to MrNv VLP.
Relative dissociation constant (K rel D ) of phagedisplayed peptides and MrNv VLP K rel D values of the interactions between phage-displayed peptides (phage-HTK and phage-VSR) and MrNv VLP were determined as described by Dyson et al. [23] and Tan et al. [24] . The percentage of free phages decreased with the increased concentrations of MrNv VLP (Fig. 3) (Fig. 4 ). An unrelated peptide, MHRSLLGRMKGA, which is a ligand of HBcAg [25] , was used as a negative control and did not inhibit the cellular entry of MrNv VLP. All peptides used in this experiment were not cytotoxic to the Sf9 cells (Fig. S4) .
In vitro inhibition of the infection of native MrNv by synthetic peptides Cytopathic effects including enlargement of cellular size and vacuolation were observed in the Sf9 cells inoculated with native MrNv (Fig. 5, arrows) , as compared to the untreated Sf9 cells which were uniform in size and morphology. When peptide HTKQIPRHIYSA, peptide VSRHQSWHPHDL and the rabbit anti-MrNv capsid protein serum were added with the virus and the mixtures were used to infect Sf9 cells (namely pre-infection), the cytopathic effects reduced, suggesting that these peptides have some anti-MrNv properties. However, the peptides did not reduce cytopathic effects when they were added to the cells which had been infected with virus for 3 h (namely post-infection). Besides, the cytopathic effects were reduced when peptide HTKQIPRHIYSA, peptide VSRHQSWHPHDL, or the serum was added during both pre-and post-infections. The unrelated peptide MHRSLLGRMKGA, which served as a negative control, did not reduce the cytopathic effects of the infected cells.
Apart from showing cytopathic effects, the growth of Sf9 cells infected by native MrNv was also slowed down ( Fig. 5) .
After 72 h of culturing, the native MrNv-infected cells were about 60 % confluency, as compared with 95 % confluency of the untreated cells. The Sf9 cells infected by MrNv which had been mixed with peptide HTKQIPRHIYSA, peptide VSRHQSWHPHDL or the rabbit anti-MrNv capsid protein serum during pre-infection, showed a higher confluency. However, when peptide HTKQIPRHIYSA, peptide VSRHQSWHPHDL or the serum was added to cells during post-infection, only the serum increased the cellular confluency. Higher confluency was also observed when peptide HTKQIPRHIYSA, peptide VSRHQSWHPHDL or serum was added during pre-and post-infections. Peptide MHRSLLGRMKGA did not inhibit MrNv infection, hence the infected Sf9 cells showed a lower confluency.
MTT assay was applied to quantify the viability of Sf9 cells inoculated with native MrNv. As shown in Fig. 6 (a), the untreated Sf9 cells represent 100 % of viability, and the viability of native MrNv-infected Sf9 cells reduced to 65±2 %. The Sf9 cells infected with native MrNv which had been treated with the rabbit anti-MrNv capsid protein serum, peptide HTKQIPRHIYSA and peptide VSRHQSWHPHDL during pre-infection, showed significantly higher viability with 98±2, 91±2 and 89±1 %, respectively. By combining both peptides HTKQIPRHIYSA and VSRHQSWHPHDL, the viability further increased to 97±3 %, which is comparable to the inhibitory effect of the rabbit anti-MrNv capsid protein serum. However, when Sf9 cells were added with peptides during post-infection, the viability of cells did not show a significant difference from that of infected cells without the addition of peptides. Besides, there was also no significant difference in viability between peptides added during pre-infection and the peptides added during pre-and post-infections. 
DISCUSSION
MrNv is the causative agent of WTD in giant freshwater prawns. Infected post-larvae of the prawns show 100 % mortality within three days after the appearance of symptoms, causing great economic loss in the prawn industry. For the past two decades, research on WTD was mainly focused on diagnosis using either immunological or genome-based methods [26] , and prevention of WTD using immunostimulants such as natural products [27] [28] [29] , recombinant MrNv capsid protein [30] , or recombinant RNA-dependent RNA polymerase of MrNv [31] . However, until now, there is no specific antiviral agent against MrNv.
Biopanning is commonly used to screen for high affinity ligands against a particular target from a phage-displayed peptide library. The isolated peptides have high binding affinities towards their targets, with K D values ranging from nano to micro molar [24, 32, 33] . Therefore, this technique has been widely applied to screen for anti-viral peptides against dengue virus [34] , hepatitis B virus [24, 32] , white The underlined residues show proline and arginine residues adjacent to histidine residues.
spot syndrome virus [19] , Japanese encephalitis virus [33] and many other viruses [35] .
Recombinant MrNv capsid protein produced in E. coli selfassembled into VLP but it is smaller than the native MrNv. Sun et al. [36] and Cadena-Nava et al. [37] demonstrated that the size of viral particles was affected by the size of their packaged cargo. Our previous study [13] The rabbit anti-MrNv capsid protein serum inhibited the binding of phage-HTK and phage-VSR to MrNv VLP. This inhibitory effect might be caused by competition between the phages and polyclonal antibodies for the same binding sites on the MrNv VLP. Sf9 cells were previously used to study the entry and localization of MrNv VLP [15] . Therefore, in the present study we used Sf9 cells to study the inhibitory activity of the selected peptides on the entry of MrNv VLP. The two synthetic peptides, HTKQIPRHIYSA and VSRHQSWHPHDL, inhibited the entry of MrNv VLP. A significantly higher inhibitory activity was achieved when both peptides were added together, demonstrating a greater blocking of MrNv VLP entry in the presence of both peptides.
Sf9 cells infected by native MrNv showed cytopathic effects including swelling and vacuolation. These cytopathic effects correlate well with those reported by Somrit et al. [40] which support the susceptibility of Sf9 cells to native MrNv infection. In the presence of both peptides HTKQIPR-HIYSA and VSRHQSWHPHDL, the infected cells showed lesser cytopathic effects, higher cellular confluency, higher cellular viability and lower intracellular virus particle, demonstrating the peptides possess anti-MrNv property. To determine the inhibitory mechanism of peptides HTKQIPRHIYSA and VSRHQSWHPHDL against MrNv, the peptides were applied to Sf9 cells at different periods of MrNv infection. The peptides inhibited MrNv when they were added to the virus during pre-infection, suggesting the peptides inhibit viral entry. By contrast, no significant inhibitory activity was observed when the peptides were added to the cells during post-infection. This result indicated that the peptides could not inhibit MrNv after the virus had attached and internalized into the cells. In addition, when the peptides were mixed with MrNv during preinfection and also added to cells during post-infection, the inhibitory effect has no significant difference when compared with the adding of peptides during pre-infection. This confirms that the peptides only inhibited virus entry but did not inhibit the virus anymore after it had entered into the cells. This inhibitory activity can be explained by the fact that the peptides were selected against MrNv capsid protein, the constituent of the native virus. By binding on the surface of MrNv, these peptides block the attachment of the virus to In the present study, the two selected peptides (HTKQIPR-HIYSA and VSRHQSWHPHDL) have rather high IC 50 values, however they are lead peptides for identification of amino acid residues which are essential for binding with MrNv capsid. Mutageneses of these residues would give rise to peptides with higher binding affinities towards MrNv, thus increasing the inhibitory activity of the mutated peptides. Real-time RT-PCR results revealed that simultaneous application of both peptides significantly reduced the number of MrNv/Sf9 cell from 97±9 to 11±4, demonstrating a considerable reduction in the viral entry. In addition, the peptides selected in the present study could be combined with other compounds which inhibit the viral replication and morphogenesis to further enhance the inhibition of MrNv life cycle.
In summary, two peptides with the sequence HTKQIPR-HIYSA and VSRHQSWHPHDL that interacted tightly with MrNv VLP were isolated from a phage-displayed peptide library. Both peptides inhibited the entry of the MrNv VLP into Sf9 cells and inhibited the infection of native MrNv in Sf9 cells. These peptides serve as potential anti-MrNv lead candidates. Elucidation of the virus-peptide structure at atomic resolution would provide insights into the peptides' binding sites and their mechanisms of inhibition.
METHODS
Cell culture Sf9 cells were cultured in Sf-900 II SFM liquid medium (Gibco) containing 5 % (v/v) FBS (Sigma) at 25 C.
Production and purification of MrNv and tHBcAg VLPs
Production and purification of MrNv and tHBcAg VLPs were performed as described by Goh et al. [7] and Tan et al. [41] , respectively. The purified VLPs were quantified using the Bradford assay [42] .
Purification of native MrNv
A two-step RT-PCR was used to verify the presence of native MrNv in infected post-larvae of M. rosenbergii. First, total RNA molecules were extracted from the post-larvae using the TRIzol LS Reagent (Invitrogen) by following the manufacturer's protocol. TA Forward (5¢-AAC ATC AAG ATG GCT AGA GGT AAA C-3¢) and TA Reverse (5¢-ATT ATT GCC GAC GAT AGC TCT G-3¢) primers [7] were used to amplify the MrNv gene. For reverse transcription, primer annealing was performed at 25 C for 5 min, followed by cDNA synthesis at 42 C for 30 min. Then, reverse transcriptase was inactivated at 85 C for 5 min. PCR was started with an initial DNA denaturation at 95 C for 5 min, followed by DNA amplification for 30 cycles (denaturation at 94 C for 45 s; annealing at 50.3 C for 1 min; extension at 72 C for 1 min 15 s) and a final extension at 72 C for 5 min. The RT-PCR product was analysed with 1 % (w/v) agarose gel electrophoresis.
Native MrNv was purified from the infected post-larvae with sucrose density gradient ultracentrifugation. The lysate of MrNv-infected post-larvae was prepared according to Somrit et al. [40] with some modifications. Briefly, the postlarvae [20 % (w/v) in HEPES buffer (25 mM HEPES, 150 mM NaCl; pH7.4)] were homogenized and then centrifuged at 6000 g for 10 min at 4 C. The collected supernatant was further centrifuged at 12 100 g for 30 min at 4 C. The supernatant was loaded onto a sucrose density gradient [8-50 % (w/v) in HEPES buffer] and centrifuged at 210 000 g for 4 h 30 min at 4 C. The collected fractions (500 µl) were then analysed with SDS-PAGE and Western blotting. The middle fractions containing native MrNv were pooled, dialysed in HEPES buffer to remove sucrose, and concentrated using a 10 kDa Vivaspin Turbo 15 centrifugal concentrator (Sartorius). The protein concentration of purified native MrNv was quantified using the Bradford assay [42] .
SDS-PAGE and Western blotting
The MrNv VLP, tHBcAg VLPs and native MrNv were analysed with SDS-PAGE. The MrNv VLP and native MrNv were further characterized with Western blotting using the rabbit anti-MrNv capsid protein serum [1 : 2500 dilution in TBS (50 mM Tris-HCl, 150 mM NaCl; pH7.4)] as the primary antibody and the goat anti-rabbit antibody conjugated to alkaline phosphatase (1 : 5000 dilution in TBS; KPL) as the secondary antibody.
Transmission electron microscopy (TEM)
The MrNv VLP, tHBcAg VLP, and native MrNv (25-100 µg ml À1 ; 15 µl) were absorbed onto 300-mesh carbon coated/ formvar copper grids (Agar Scientific) and stained negatively with uranyl acetate [2 % (w/v); 15 µl]. The grids were viewed under a TEM (Hitachi H-7700, Hitachi).
Selection of peptides that interact with MrNv VLP
The Ph.D.-12 phage-displayed peptide library (New England Biolabs) was employed to identify peptides that interact with MrNv VLP. Round bottom 96-well plates (Greiner Bio-One) were coated with the MrNv VLP (10 µg ml
À1
; 100 µl) and the coated wells were then blocked with BSA (5 mg ml ). The eluted phages were neutralized with Tris-HCl (1 M; pH9.1; 30 µl) and amplified by infecting E. coli ER2738. The amplified phages were titred using the plaque assay as described by Tan et al. [24] , and then used in the next round of biopanning. Together, four rounds of biopanning were performed. To increase the stringency of selection, the percentage of Tween 20 in TBST was increased in subsequent rounds of biopanning: 0.1, 0.2, 0.3 and 0.5 % (v/ v) in the first, second, third and fourth rounds, respectively.
Determination of peptide sequence
The nucleotide inserts of the isolated phage clones were sequenced using the 96 gIII reverse sequencing primer, 5¢-CCC TCA TAG TTA GCG TAA CG-3¢. The amino acid residues of the phage-displayed peptides were deduced from the nucleotide sequences. The characteristics of the peptides were predicted using the Expasy ProtParam Tool [43] .
Large-scale purification of the isolated phages Two dominant phage clones bearing the peptide sequences HTKQIPRHIYSA (phage-HTK) and VSRHQSWHPHDL (phage-VSR) were produced in large-scale. These phages were propagated in E. coli ER2738 cultured in Luria-Bertani (LB) broth (1 l) for 16 h at 37 C. Phage particles in the supernatant were precipitated by polyethylene glycol (PEG; 8 kDa) and purified with caesium chloride density gradient ultracentrifugation as described by Smith and Scott [44] .
Antibody-phage competition assay
A series of different phage concentrations (10 7 -10 11 p.f.u. ml À1 ) were mixed with the rabbit anti-MrNv capsid protein serum (1 : 1000 dilution) in TBS. The mixtures (100 µl) were added into the wells coated with MrNv VLP (10 µg ml À1 ; 100 µl) or tHBcAg VLP (10 µg ml À1 ; 100 µl). After incubating at 4 C for 2 h, the wells were washed ten times with TBST. Bound phages were detected using the HRP-conjugated anti-M13 monoclonal antibody (100 µl; 1 : 1000 dilution in TBS; GE Healthcare). The phages alone and phages incubated with the rabbit anti-HBcAg serum were used as controls [22] .
Determination of the binding affinity of phagedisplayed peptides
The K rel D values of the interactions between MrNv VLP with the phage-displayed peptides were determined as described by Dyson et al. [23] and Tan et al. [24] . Different concentrations of MrNv VLP (0.1-4000 nM) were incubated with phage-displayed peptides (1Â10 10 p.f.u. ml
À1
) in TBS, for 18 h at 4 C. Aliquots (100 µl) of each complex mixture were transferred into microtitre plate wells coated with MrNv VLP (10 µg ml
; 100 µl) and incubated for 2 h at 4 C. After washing the plate ten times with TBST, the free phages interacted with the MrNv VLP coated on the plate were eluted and their p.f.u. was determined by plaque assay. The percentage of free phage versus the concentration of MrNv VLP in the mixtures was plotted and the K rel D values were determined by fitting a curve to these points using the equation for one binding site (GraFit version 3.0, Erithacus Software).
Cytotoxicity test of synthetic peptides
Peptides HTKQIPRHIYSA, VSRHQSWHPHDL and MHRSLLGRMKGA were synthesized (GL Biochem). Stock solutions (1 mg ml À1 in HEPES buffer) of the peptides were prepared and stored at À20
C. The synthetic peptides (0.5-500 µM) were incubated with Sf9 cells in Sf-900 II SFM liquid medium (Gibco) containing 5 % (v/v) FBS (Sigma) for 72 h at 25 C. MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; 5 mg ml À1 in PBS; 20 µl] was added into each well and incubated for 4 h. The solution in each well was removed and DMSO (100 µl) was added into the wells to dissolve the formazan crystal formed by the viable cells. A 570 was determined using an ELISA plate reader (ELx800, Bio-Tek Instruments).
Inhibition of cellular internalization of MrNv VLP by synthetic peptides Inhibitory effect of the peptides on the internalization of MrNv VLP into Sf9 cells was determined using in-cell ELISA [45] . Peptides HTKQIPRHIYSA and VSRHQSWHPHDL (0.1-500 µM) were incubated with the MrNv VLP (10 µg ml C. After washing eight times with PBST, substrate solution (1 mg ml À1 p-nitrophenyl phosphate, 0.5 mM MgCl 2 , 1 M diethanolamine; pH9.8; 100 µl) was added and the plates were incubated in dark for 15 min at 25 C. A 405 was measured using an ELISA plate reader (ELx800, BioTek Instruments).
In vitro inhibition of native MrNv infection by synthetic peptides
First, in the pre-infection experiment, peptides HTKQIPR-HIYSA and VSRHQSWHPHDL (500 µM) were incubated with the native MrNv (250 µg ml C. The MrNv-serum or MrNv-peptide mixtures were then added to Sf9 cells in 96-well plates, and incubated for 3 h at 25 C. Next, the mixtures were replaced with fresh Sf-900 II SFM liquid media (200 µl) containing 5 % (v/v) FBS, and peptides (500 µM) or the rabbit antiMrNv capsid protein serum (1 : 1000 dilution). After incubation for 72 h at 25 C, the cytopathic effect and cellular confluency of the Sf9 cells in these three experiments were examined under an inverted light microscope. The viability of the Sf9 cells was determined using the MTT assay.
The number of native MrNv in Sf9 cells in the pre-infection, post-infection, and pre-and post-infection treatments, was determined using the real-time RT-PCR assay. Total RNA in the cells were extracted using the TRIzol LS reagent (Invitrogen) by following the manufacturer's protocol. cDNA was synthesized from the extracted RNA as described in the purification of native MrNv. The primers used in this assay were qPCR Forward (5¢-ACA ACA ACT ATT CCA TTG-3¢) and qPCR Reverse (5¢-AGA GGT AAA ATA CAC CCT G-3¢). The qPCR probe (5¢-CGT TCT CCT TAT CTT GAC CAG TAT AGT-3¢) was labelled with the fluorescent reporter dye 6-carboxy-fluorescein and the quencher Black Hole Quencher 1 at 5¢-and 3¢-ends, respectively. A standard curve was plotted from a 10-fold serial dilution of the recombinant plasmid DNA, namely pTrcHisTARNA2, carrying the insert of RNA2 gene [7] . The PCR mixture (20 µl) contained 1ÂSsoadvanced Universal Probes Supermix (BioRad Laboratories), 500 nM of both qPCR Forward and qPCR Reverse primers, 500 nM of qPCR probe, and 2 µl of cDNA or plasmid DNA template. DEPC-treated nuclease free water (Sigma) was used as a non-template control. The thermal cycling conditions were an initial denaturation at 95 C for 3 min, followed by 40 cycles of denaturation at 94 C for 30 s, annealing at 54 C for 30 s, and an extension at 70 C for 20 s. The real-time PCR running condition was performed with a CFX96 qPCR detection system (Bio-Rad Laboratories) and fluorescence was measured after each cycle. Data were analysed by using the Bio-Rad CFX Manager software (version 3.1; Bio-Rad Laboratories).
Statistical analysis
The significant difference between tested groups was determined with the one-way ANOVA and Tukey's HSD test, using the SPSS software. P-values of less than 0.05 were considered significant. 
